Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for 60 Degrees Pharmaceuticals Inc. (SXTP:NASDAQ), powered by AI.
60 Degrees Pharmaceuticals Inc. is currently trading at $1.36. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for 60 Degrees Pharmaceuticals Inc. on Alpha Lenz.
View 60 Degrees Pharmaceuticals Inc.'s valuation metrics on Alpha Lenz.
“60 Degrees Pharmaceuticals Inc.'s ROE is -196.4%. Explore profitability and growth together.”
Ask for details →60 Degrees Pharmaceuticals Inc. is a biotechnology company that specializes in the discovery, development, and commercialization of treatments for infectious diseases, particularly those impacting travelers and other affected populations. The company is renowned for its focused efforts on addressing tropical diseases, leveraging its expertise to offer solutions where medical needs are unmet, such as malaria prevention. With innovative approaches in pharmaceutical research and development, 60 Degrees Pharmaceuticals Inc. plays a vital role in the pharmaceutical sector, enhancing healthcare outcomes. Its contributions are significant, as it targets diseases prevalent in underserved regions, working towards creating sustainable health solutions globally. The company's focus on bringing advanced health innovations to the market positions it as a key player in addressing global health challenges, while its strategic research initiatives underline its importance in both the biotechnology landscape and global public health efforts.
“60 Degrees Pharmaceuticals Inc.'s ROE is -196.4%. Explore profitability and growth together.”
Ask for details →60 Degrees Pharmaceuticals Inc. (ticker: SXTP) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 3 employees.
The current price is $1.36 with a P/E ratio of -x and P/B of -x.
ROE is -196.44% and operating margin is -771.64%. Annual revenue is $1M.